Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom and uses thereof

Details for Australian Patent Application No. 2003224601 (hide)

International Classifications

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 10/346,021 16.01.03 US; 10/052,323 18.01.02 US; 10/116,963 05.04.02 US

9 October 2003 Application Open to Public Inspection

Published as AU-B-2003224601

9 December 2004 Amendment Made

The nature of the amendment is: Amend the priority details from Not Given 16 Jan 2003 US to 10/346,021 16 Jan 2003 US. 2003226926 7TM Pharma A/S The nature of the amendment is: Amend the name of the co-inventor from Bjurling, Anna Emelie to Bjurling, Emelie.

4 December 2008 Application Accepted

Published as AU-B-2003224601

29 January 2009 Section 223 Application Allowed

The UAB Research Foundation The time in which to pay a response fee has been extended to 02 Feb 2009. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005 2008

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.